(Q38650323)

5 September 2017

title

Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians (English)

1 reference

5 September 2017

1

Alison C Bested

1 reference

5 September 2017

Lynn M Marshall

2

1 reference

5 September 2017

publication date

1 December 2015

1 reference

Reviews on Environmental Health

5 September 2017

published in

1 reference

5 September 2017

volume

30

1 reference

5 September 2017

issue

4

1 reference

5 September 2017

page(s)

223-249

1 reference

Higher heart rate and reduced heart rate variability persist during sleep in chronic fatigue syndrome: a population-based study.

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Unintended Consequences of not Specifying Exclusionary Illnesses for Systemic Exertion Intolerance Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Regional distribution of fatiguing illnesses in the United States: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Impaired cardiovascular response to standing in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Ventricular cerebrospinal fluid lactate is increased in chronic fatigue syndrome compared with generalized anxiety disorder: an in vivo 3.0 T (1)H MRS imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Neuroinflammation in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An ¹¹C-(R)-PK11195 PET Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

A controlled clinical trial with a specifically configured RNA drug, poly(I).poly(C12U), in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Chronic fatigue syndrome, the immune system and viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

A formal analysis of cytokine networks in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Is neurally mediated hypotension an unrecognised cause of chronic fatigue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Predictors of Post-Infectious Chronic Fatigue Syndrome in Adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

The impact of energy modulation on physical functioning and fatigue severity among patients with ME/CFS

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Cognitive functioning in people with chronic fatigue syndrome: a comparison between subjective and objective measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Postexertional malaise in women with chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Chronic fatigue syndrome: illness severity, sedentary lifestyle, blood volume and evidence of diminished cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

A twin study of cognitive function in chronic fatigue syndrome: the effects of sudden illness onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Myalgic encephalomyelitis: International Consensus Criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Unidentified Chronic Fatigue Syndrome/myalgic encephalomyelitis (CFS/ME) is a major cause of school absence: surveillance outcomes from school-based clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Validating a measure of myalgic encephalomyelitis/chronic fatigue syndrome symptomatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Chronic fatigue syndrome: a working case definition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Biochemical evidence for a novel low molecular weight 2-5A-dependent RNase L in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Impaired natural immunity, cognitive dysfunction, and physical symptoms in patients with chronic fatigue syndrome: preliminary evidence for a subgroup?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

The prognosis of chronic fatigue and chronic fatigue syndrome: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Life-events and the course of chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Conceptual model for physical therapist management of chronic fatigue syndrome/myalgic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Mortality in a cohort of chronically fatigued patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Increased ventricular lactate in chronic fatigue syndrome measured by 1H MRS imaging at 3.0 T. II: comparison with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Increased concentrations of homocysteine in the cerebrospinal fluid in patients with fibromyalgia and chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Exercise therapy for chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Distinct plasma immune signatures in ME/CFS are present early in the course of illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Slow wave sleep in the chronically fatigued: Power spectra distribution patterns in chronic fatigue syndrome and primary insomnia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Non-REM sleep EEG power distribution in fatigue and sleepiness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Coincidence of immune-mediated diseases driven by Th1 and Th2 subsets suggests a common aetiology. A population-based study using computerized general practice data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

A community-based study of chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Serum 25-hydroxy vitamin D levels in chronic fatigue syndrome: a retrospective survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Neuroendocrine and immune network re-modeling in chronic fatigue syndrome: an exploratory analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Alternative medical interventions used in the treatment and management of myalgic encephalomyelitis/chronic fatigue syndrome and fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

How Science Can Stigmatize: The Case of Chronic Fatigue Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Longitudinal analysis of symptoms reported by patients with chronic fatigue syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Attention network test: assessment of cognitive function in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

21 January 2018

Twin analyses of fatigue

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Factors influencing the diagnosis of chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Defining the occurrence and influence of alpha-delta sleep in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Chronic fatigue syndrome after infectious mononucleosis in adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Illness trajectories in the chronic fatigue syndrome: a longitudinal study of improvers versus non-improvers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Does the chronic fatigue syndrome involve the autonomic nervous system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Use of single-nucleotide polymorphisms (SNPs) to distinguish gene expression subtypes of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Sub-typing daily fatigue progression in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

The hospital anxiety and depression scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Changes in growth hormone, insulin, insulinlike growth factors (IGFs), and IGF-binding protein-1 in chronic fatigue syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Classification of myalgic encephalomyelitis/chronic fatigue syndrome by types of fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Cognitive performance is of clinical importance, but is unrelated to pain severity in women with chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Understanding long-term outcomes of chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Treatment of insomnia in adults and children: a practice-friendly review of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

A Twin Study of the Etiology of Prolonged Fatigue and Immune Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH-2015-0026

21 January 2018

Identifiers

DOI

10.1515/REVEH-2015-0026

1 reference

5 September 2017

1 reference